OPTINOSE, INC. Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
OPTINOSE, INC. reported Increase (Decrease) in Other Accounts Payable and Accrued Liabilities of -$5.41 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities · last filed 2025-05-14
- OPTINOSE, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2025-03-31 was -$5.41M.
- OPTINOSE, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2024-12-31 was $2.49M, a 80.77% decline year-over-year.
- OPTINOSE, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2024-03-31 was -$11.52M.
- OPTINOSE, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2023-12-31 was $12.94M.
- OPTINOSE, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2024 was -$8.08M.
- OPTINOSE, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2023 was -$3.53M.
| Period end | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2025-03-31 | -$5.41M 10-Q · filed 2025-05-14 | -$2.92M derived: sum of 2 quarters · filed 2025-05-14 | ||
| 2024-12-31 | $2.49M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | -$8.08M 10-K · filed 2025-03-26 | ||
| 2024-09-30 | -$10.57M 10-Q · filed 2024-11-12 | |||
| 2024-03-31 | -$11.52M 10-Q · filed 2025-05-14 | $1.42M derived: sum of 2 quarters · filed 2025-05-14 | ||
| 2023-12-31 | $12.94M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | -$3.53M 10-K · filed 2025-03-26 | ||
| 2023-09-30 | -$16.47M 10-Q · filed 2024-11-12 |